ArticlePloS one2018

Cost-benefit analysis of introducing next-generation sequencing (metagenomic) pathogen testing in the setting of pyrexia of unknown origin.

Jia Hui Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.